“Meet patients where they’re at” is another way of speaking to the reduced burden we can expect when #clinicaltrials are designed pragmatically. Hear from Flatiron’s Director of Clinical Operations, Josh Buddle on the potential of post-marketing evidence generation. To learn why it’s critical to capitalize on this opportunity, watch the full episode with ResearchRevolution here: http://spkl.io/604147xe9
Flatiron Health
Biotechnology Research
New York, New York 75,733 followers
Reimagining the infrastructure of cancer care
About us
Flatiron Health’s mission is to improve and extend lives by learning from the experience of every person with cancer.
- Website
-
http://www.flatiron.com
External link for Flatiron Health
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- New York, New York
- Type
- Privately Held
Locations
-
Primary
233 Spring St
5th Floor
New York, New York 10013, US
Employees at Flatiron Health
-
Elia Brandao
-
Michelle Cadrin-Msumba
Solution Design Manager // Medical Practice Management // Revenue Cycle Management // Enabling sales with data and technology // On site Needs…
-
Rahul Bafna
Healthcare Technology Product Leader
-
Mariano Peterson
Engineering Leader in Platform, Cloud, and Infrastructure
Updates
-
Hear from the authors of a recent JCO publication review their research findings on EHR-to-EDC technology in #clinicaltrials and how it can reduce data management burden and enhance overall efficiency. ⭐ "Utility of automated data transfer for cancer clinical trials” 📅 Wednesday, July 17th at 11 AM: http://spkl.io/604847xeK
-
-
#RWE and cross-industry collaborations are critical to driving innovative solutions that improve and extend the lives of people with #lungcancer. With 230,000 new cases of lung cancer a year in the United States, it remains one of the most active areas of #cancerresearch today. Flatiron’s VP of Evidence Client Solutions, Christine Hung, shared her perspective on opportunities for lung cancer research and three industry case studies where #RWE supported critical research across the biopharma lifecycle. Read more now: http://spkl.io/6043470af
-
-
After learning about David Fajgenbaum, MD, MBA, MSc’s journey with a rare form of Castleman disease, Flatiron engineers utilized #machinelearning to better leverage Flatiron data, unlocking previously unreachable insights for a rare patient population to drive improved treatments and understanding of the disease. Read our #LearnTeachGrow article to gain a behind the scenes look at how their work using #ML enabled them to scale the identification of specific patient cohorts and ultimately inform treatment opportunities. https://lnkd.in/e2aWaJ3g
-
Join a panel of experts from AstraZeneca, University of Pennsylvania School of Medicine, and Regional Cancer Care Associates for an upcoming webinar on the state of breast cancer research today. The panel will be answering live questions and discuss: - How organizations across the healthcare industry are tackling complex clinical decision-making - The use of #AI to accelerate #breastcancer research and clinical practice - Treatment selection, sequencing and the increasingly critical role of genomic testing ‘Bridging Innovation & Practice: The Current & Future Landscape of Breast Cancer Care' 📅Tues, July 23 12-1 PM ET Secure your spot & ask our panel of experts your questions directly. Register & submit questions now: http://spkl.io/604147rlF
-
On the latest Vator podcast, Flatiron Health's SVP of Real-World Evidence Stephanie Reisinger spoke to Steven Loeb and Bambi Francisco to discuss how Flatiron is: 💡 Empowering research by making data actionable 🔬 Partnering with biopharma to accelerate drug development 🔎 Harnessing #AI and #ML to uncover insights at scale ✨ Collaborating with AMCs to democratize access to data 🧬 Enabling personalized medicine by understanding the full patient's journey Tune in to learn more on how Flatiron is harnessing the power of real-world evidence: https://lnkd.in/eAeShmss
Stephanie Reisinger, SVP of Real-World Evidence at Flatiron Health, on the VatorNews podcast
vator.tv
-
RECENTLY ANNOUNCED: Flatiron Health’s newly launched Trusted Partners Network is a curated selection of technology and service providers with proven positive impact in oncology. This initiative helps partners expand their reach and drives greater value for community oncology. Read more from Flatiron's VP, Strategic Partnerships and Alliances, Nina Chavez https://lnkd.in/eY_63UiW
Empowering Community Oncology: Flatiron Health's Trusted Partner Network
resources.flatiron.com
-
Hear from the authors of the American Society of Clinical Oncology (ASCO) JCO publication “Utility of automated data transfer for cancer clinical trials” as they review their research findings on EHR-to-EDC technology in #clinicaltrials and how it can reduce data management burden and enhance overall efficiency. 📆 Join us on July 17th at 11 am to walk away with: - Tangible examples of how EHR-to-EDC technology is increasing the efficiency of trial data acquisition and management and lowering the burden to site staff - Suggested change management strategies for successful implementation https://lnkd.in/etmGFYAR
-
-
#Clinicaltrials are often burdensome and inefficient for practices. But the right technology can more seamlessly integrate research into everyday clinical care. Hear Kathy Oubre, CEO of Pontchartrain Cancer Center (PCC), share how Flatiron’s OncoEMR & OncoTrials streamline their research operations across 21 trials, serving over 120 patients. Watch now to learn more about these solutions, and why PCC said they take their research program “to another level.” http://spkl.io/60474A4A3
COA insights: Scaling research operations at community oncology practices
resources.flatiron.com
-
A new report, recently published by an ISPOR Task Force including Flatiron’s Blythe Adamson, PhD, MPH and other industry experts, provides actionable takeaways for HTA agencies and policymakers supporting and potentially standardizing the use of EHR-derived #RWD for #HTAs. Introducing a framework and accompanying ISPOR SUITABILITY Checklist, this ISPOR Good Practices Report addresses the validity and relevance of EHR-derived #RWD to fill evidence gaps and improve decision-making. Visit our website for the full report and to learn more about why this matters ⬇️ http://spkl.io/604047y5i
-